Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 406568, 12 pages
http://dx.doi.org/10.1155/2012/406568
Research Article

Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer

1Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
2Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
3Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
4Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
5Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA

Received 16 April 2012; Accepted 15 May 2012

Academic Editor: Nikolaos Touroutoglou

Copyright © 2012 Jessica A. Smith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jessica A. Smith, Aaron T. Wild, Aatur Singhi, et al., “Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer,” International Journal of Surgical Oncology, vol. 2012, Article ID 406568, 12 pages, 2012. https://doi.org/10.1155/2012/406568.